Anti-Human TRAIL (CT)
Anti-Human TRAIL (CT) (T202-GRP)
Products
Description
TNF-related apoptosis-inducing ligand (TRAIL) belongs to the tumor necrosis factor family and activates rapid apoptosis in tumor cells, and binds to the death-signaling receptor DR4.1 TRAIL is a potential tumor specific cancer therapeutic agent, since it selectively induces apoptosis in transformed versus normal cells.2
Specifications
| Manufacturer | Leinco Technologies Inc |
|---|---|
| Manufacturer Cat# | T202 |
| Concentration | 0.5 mg/ml |
| Formulation | This polyclonal antibody is formulated in phosphate buffered saline (PBS) pH 7.4 containing 0.02% sodium azide as a preservative. |
| Alternate Names | Polyclonal Antibody TNF-Related Apoptosis-Inducing Ligand TNFSF10 APO2L Apo-2L CD253 TL2 TRAIL Human Anti-Human TRAIL (CT) |
| Target | TNF-Related Apoptosis-Inducing Ligand |
| Antibody Type | Polyclonal |
| Applications | IHC FFPE, WB |
| Storage | This polyclonal antibody is stable for at least one week when stored at 2-8°C. For long term storage, aliquot in working volumes without diluting and store at –20°C in a manual defrost freezer. Avoid Repeated Freeze Thaw Cycles. |
| Protein | TNF-Related Apoptosis-Inducing Ligand |